Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0139 EUR | -1,42% | -2,11% | -77,29% |
11/04 | BioSenic dient herstructureringsplan in | AM |
20/03 | BioSenic presenteert succesvolle studiedata op het Systemic Sclerosis World Congress 2024 | AM |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 2,59 mln. 2,78 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -5 mln. -5,37 mln. | Nettowinst (verlies) 2024 * | -11 mln. -11,82 mln. | EV/omzet 2023 * | - |
Nettoschuld 2023 * | 18,8 mln. 20,2 mln. | Nettoschuld 2024 * | 29,3 mln. 31,48 mln. | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,28
x | K/w-verhouding 2024 * |
-0,16
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 75,65% |
1 dag | -4,73% | ||
1 week | -4,73% | ||
Lopende maand | -4,73% | ||
1 maand | -42,21% | ||
3 maanden | -62,70% | ||
6 maanden | -73,69% | ||
Lopend jaar | -76,96% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Francois Rieger
CEO | Chief Executive Officer | - | - |
Lieven Huysse
CTO | Chief Tech/Sci/R&D Officer | - | 03-04-23 |
Nicco Carole
COO | Chief Operating Officer | - | 18-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | - | |
Director/Board Member | 53 | - | |
Francois Rieger
CEO | Chief Executive Officer | - | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
08-05-24 | 0,0139 | -1,42% | 1 506 443 |
07-05-24 | 0,0141 | -4,73% | 2 938 253 |
06-05-24 | 0,0148 | +8,03% | 890 152 |
03-05-24 | 0,0137 | -3,52% | 594 190 |
02-05-24 | 0,0142 | -4,05% | 1 241 022 |
Real Time Euronext Bruxelles, 07 mei 2024 om 15:58 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-76,96% | 2,79 mln. | |
+33,43% | 700 mld. | |
+26,43% | 569 mld. | |
-5,12% | 358 mld. | |
+19,59% | 330 mld. | |
+4,89% | 287 mld. | |
+14,32% | 236 mld. | |
+5,79% | 202 mld. | |
-9,49% | 197 mld. | |
+4,26% | 161 mld. |